Mayo Clinic executive picked to lead bioscience research center in Colorado

Steven VanNurden is currently the chair of Mayo Clinic Ventures. Under his guidance, the division has commercialized more than 2,000 technologies; was granted more than 1,200 patents and helped form more than 45 start-up companies. VanNurden will begin his new role as President and Chief Executive of the Fitzsimons Redevelopment Authority in late May.
Author:
Updated:
Original:

Steven VanNurden is currently the chair of Mayo Clinic Ventures. Under his guidance, the division has commercialized more than 2,000 technologies; was granted more than 1,200 patents and helped form more than 45 start-up companies. VanNurden will begin his new role as President and Chief Executive of the Fitzsimons Redevelopment Authority in late May.

Next Up

Related

Longtime news stand in the Mayo Clinic Gonda building near its end

After more than 5.5 decades the Kaplan family's Subway News Stand in downtown Rochester will ring up its last sale on Aug. 31, the Post Bulletin reports. Declining sales, changes in the industry and rising prices convinced 84-year-old Ben Kaplan and his nephew it was time to close up shop. There's no word yet what Mayo Clinic has planned for the space.

Mayo Clinic wins major patent victory

The Supreme Court sided unanimously with Mayo in a patent dispute with California-based Prometheus Laboratories. The clinic had used a blood test developed by Prometheus until 2004, when it developed its own in-house test. Prometheus sued for patent infringement, but Mayo argued that using test to measure a natural bodily process is not patent eligible.